Americana Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Americana Partners's AZN Position: Q2 2026 in Review
Americana Partners increased its AstraZeneca (AZN) stake by 0.23% in Q2 2026, buying an estimated $14.9K and bringing the position to 34,739 shares worth $6.54M. The position accounts for 0.15% of the portfolio, ranked #118.
Americana Partners first reported a position in AZN in Q4 2019 and has held it in 19 quarters since. The position peaked at $6.77M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Americana Partners held 34,739 shares of AstraZeneca worth $6.54M as of Q2 2026.
- Americana Partners bought 79 AstraZeneca shares in Q2 2026, an estimated $14.9K.
- AstraZeneca made up 0.15% of Americana Partners's portfolio in Q2 2026, its #118 holding.
- Americana Partners first reported a position in AstraZeneca in Q4 2019 and has held it in 19 quarters since.
- Americana Partners's AstraZeneca position peaked at $6.77M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.